Home › Maagkanker › Pennsylvania › Philadelphia
Maagkanker klinische studies in Philadelphia, PA
15 studies voor Maagkanker zoeken deelnemers op locaties in en rond Philadelphia (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruterenGezonde vrijwilligers welkom
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mijl verwijderd
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mijl verwijderd
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RekruterenFase 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mijl verwijderd
- Alliance Cancer Specialists, PC, Media · 12 mijl verwijderd
- Alliance Cancer Specialists, PC, Horsham · 16 mijl verwijderd
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Rekruteren
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
RekruterenFase 1
- Fox Chase Cancer Center, Philadelphia
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
RekruterenFase 3
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruterenFase 3
- Research Site, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
RekruterenObservatieonderzoek
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
RekruterenFase 1/2
- University of Pennsylvania, Philadelphia
Adaptive Radiation for Abdominopelvic Metastases
RekruterenFase 1
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Philadelphia
Maagkanker studies in andere steden
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Baldwin Park, CA22 studies
- Los Angeles, CA22 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- St. Louis, MO18 studies
- Grand Rapids, MI18 studies
- Chicago, IL16 studies
Andere studies in Philadelphia
- Kanker (alle vormen)59 studies
- Borstkanker56 studies
- Niet-kleincellige longkanker51 studies
- Metastatische kanker46 studies
- Prostaatkanker44 studies
- Colorectale kanker44 studies
- Eierstokkanker44 studies
- Longkanker36 studies
- Acute myeloïde leukemie34 studies
- Hartfalen31 studies
- Endometriumkanker28 studies
- Depressie26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.